AgeTech Platform Focuses on Human-Centered Care for the Aging Population with Chase Idleman Arlow
Release Date: 03/12/2026
Empowered Patient Podcast
Lori Runion, a director at Resultant, identifies inadequate scheduling and related staffing unpredictability as a central cause of clinician burnout. Healthcare organizations traditionally rely on historical averages for scheduling, often resulting in a mismatch between patient demand and clinician capacity. Breaking down data silos and using analytics and AI to create predictive staffing models can help forecast demand, anticipate seasonal spikes, and enable proactive staffing to reduce clinician burnout. Lori explains, " From my perspective, burnout is driven at the operational level. To say...
info_outlineEmpowered Patient Podcast
Lori Runion, a director at Resultant, identifies inadequate scheduling and related staffing unpredictability as a central cause of clinician burnout. Healthcare organizations traditionally rely on historical averages for scheduling, often resulting in a mismatch between patient demand and clinician capacity. Breaking down data silos and using analytics and AI to create predictive staffing models can help forecast demand, anticipate seasonal spikes, and enable proactive staffing to reduce clinician burnout. Lori explains, " From my perspective, burnout is driven at the operational level. To say...
info_outlineEmpowered Patient Podcast
Bill Heller, Chief Operating Officer at CHG Healthcare, is focused on the significant and growing demand for physicians across numerous specialties and on providing a flexible solution for healthcare facilities to maintain services with temporary physician staffing. Rural healthcare facilities are especially dependent on temporary staffing to overcome challenges in attracting and keeping permanent medical professionals. Physicians at all career stages are drawn to locum tenens work, and it has evolved from a niche practice to a mainstream strategy for healthcare facilities and...
info_outlineEmpowered Patient Podcast
Bill Heller, Chief Operating Officer at CHG Healthcare, is focused on the significant and growing demand for physicians across numerous specialties and on providing a flexible solution for healthcare facilities to maintain services with temporary physician staffing. Rural healthcare facilities are especially dependent on temporary staffing to overcome challenges in attracting and keeping permanent medical professionals. Physicians at all career stages are drawn to locum tenens work, and it has evolved from a niche practice to a mainstream strategy for healthcare facilities and...
info_outlineEmpowered Patient Podcast
Jean-Philippe Vert, the Co-Founder and CEO of Bioptimus, is building a foundational AI model for biology to solve the problem of siloed biomedical research. Key goals are to bridge the translational gaps between drug discovery and development, and between clinical research and real-world patient outcomes, and to redesign clinical trials for greater efficiency and improved results. Creating digital twins of patients is a way to simulate treatment outcomes and create synthetic control arms for clinical trials, ultimately lowering the risk and cost of drug development and enabling the creation...
info_outlineEmpowered Patient Podcast
Jean-Philippe Vert, the Co-Founder and CEO of Bioptimus, is building a foundational AI model for biology to solve the problem of siloed biomedical research. Key goals are to bridge the translational gaps between drug discovery and development, and between clinical research and real-world patient outcomes, and to redesign clinical trials for greater efficiency and improved results. Creating digital twins of patients is a way to simulate treatment outcomes and create synthetic control arms for clinical trials, ultimately lowering the risk and cost of drug development and enabling the creation...
info_outlineEmpowered Patient Podcast
David Stamler, CEO of Alterity Therapeutics, is developing a drug to treat multiple system atrophy (MSA), a rare and rapidly progressing neurodegenerative disease that often presents as Parkinson's disease but is distinct and more aggressive. There is no single genetic cause or specific biomarker, making accurate diagnosis a significant challenge. The lead drug is a novel small molecule designed to manage excess reactive iron in the brain, which drives the disease, and may be effective for other neurodegenerative diseases involving iron dysregulation. David explains, "Multiple system atrophy...
info_outlineEmpowered Patient Podcast
David Stamler, CEO of Alterity Therapeutics, is developing a drug to treat multiple system atrophy (MSA), a rare and rapidly progressing neurodegenerative disease that often presents as Parkinson's disease but is distinct and more aggressive. There is no single genetic cause or specific biomarker, making accurate diagnosis a significant challenge. The lead drug is a novel small molecule designed to manage excess reactive iron in the brain, which drives the disease, and may be effective for other neurodegenerative diseases involving iron dysregulation. David explains, "Multiple system atrophy...
info_outlineEmpowered Patient Podcast
Greg Mayes, President and CEO of Reunion Neuroscience, and Dr. Manish Agrawal, the Co-Founder and CEO of Sunstone Therapies, shine a light on adjustment disorder, a disproportionate emotional or behavioral reaction to a significant life stressor such as a cancer diagnosis. This under-recognized condition lacks FDA-approved treatments and is often managed with SSRIs or talk therapy. The REKINDLE study evaluated the use of a psilocybin analog drug in development for treating adjustment disorder and has shown positive results by integrating emotional treatment into the standard of care for...
info_outlineEmpowered Patient Podcast
Greg Mayes, President and CEO of Reunion Neuroscience, and Dr. Manish Agrawal, the Co-Founder and CEO of Sunstone Therapies, shine a light on adjustment disorder, a disproportionate emotional or behavioral reaction to a significant life stressor such as a cancer diagnosis. This under-recognized condition lacks FDA-approved treatments and is often managed with SSRIs or talk therapy. The REKINDLE study evaluated the use of a psilocybin analog drug in development for treating adjustment disorder and has shown positive results by integrating emotional treatment into the standard of care for...
info_outlineChase Idleman, Chief Executive Officer of Arlow, is leveraging emerging AgeTech and the longevity economy to develop solutions for an aging population, their families, and caregivers. With a human-centered approach to the entire aging process, Arlow uses AI to create a system for action for adults over 65 and their support networks. The main goal is to make tasks like care coordination, document management, medication adherence, and detecting changes in behavior and physical abilities easier.
Chase explains, "AgeTech is more around the people in the population. So if you look at aging, it is not one point in time, but is truly a continuum and impacts so many people. It's not just the person who's aging, but also the family members and the entire circle of care around them. So, AgeTech is that kind of emerging field, which is how I try to differentiate it. Again, it's not product-centric, but it is really human-centric over a continuum of time."
"What we felt was the biggest opportunity was not only creating a solution for older adults, but creating a solution for the circle of care, the people every single day who are helping those older adults. And in parallel, we really started to lean in on this employer front with the workforce. So in the workforce environment, it's pretty interesting, 25% of FMLA is for caregiving. And right now, there's not a ton of solutions that can support them. So those workers are essentially the circle of care."
#Arlow #AgeTech #AI #Healthcare #Aging #Innovation #DigitalHealth #Longevity #Caregiving #HealthTech #SeniorCare #FamilyCaregivers #CaregiverBurnout #OlderAdults #EmployeeBenefits #EmployeeAssistantPrograms
